Lost in translation: Treatment trials in the SOD1 mouse and in human ALS

Acsadi, 2002, Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy, Hum. Gene Ther., 13, 1047, 10.1089/104303402753812458 Andreassen, 2000, N-acetyl-l-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis, NeuroReport, 11, 2491, 10.1097/00001756-200008030-00029 Andreassen, 2001, Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice, Exp. Neurol., 168, 419, 10.1006/exnr.2001.7633 Angelov, 2003, Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis, Proc. Natl. Acad. Sci. U. S. A., 100, 4790, 10.1073/pnas.0530191100 Anneser, 2001, Immunosuppressant FK506 does not exert beneficial effects in symptomatic G93A superoxide dismutase-1 transgenic mice, NeuroReport, 12, 2663, 10.1097/00001756-200108280-00015 Azari, 2001, Leukemia inhibitory factor by systemic administration rescues spinal motor neurons in the SOD1 G93A murine model of familial amyotrophic lateral sclerosis, Brain Res., 922, 144, 10.1016/S0006-8993(01)03156-0 Azari, 2005, Effects of intraperitoneal injection of Rofecoxib in a mouse model of ALS, Eur. J. Neurol., 12, 357, 10.1111/j.1468-1331.2004.00987.x Azzouz, 2004, VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model, Nature, 429, 413, 10.1038/nature02544 Bebarta, 2003, Emergency medicine animal research: does use of randomization and blinding affect the results?, Acad. Emerg. Med., 10, 684, 10.1111/j.1553-2712.2003.tb00056.x Benatar, 2006, Preventing familial amyotrophic lateral sclerosis: is a clinical trial feasible?, J. Neurol. Sci., 10.1016/j.jns.2006.05.069 Bordet, 2001, Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice, Hum. Mol. Genet., 10, 1925, 10.1093/hmg/10.18.1925 Canton, 2001, RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis, J. Pharmacol. Exp. Ther., 299, 314 Chang-Hong, 2005, Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis, Exp. Neurol., 194, 203, 10.1016/j.expneurol.2005.02.011 Chiba, 2006, Colivelin prolongs survival of an ALS model mouse, Biochem. Biophys. Res. Commun., 343, 793, 10.1016/j.bbrc.2006.02.184 Crow, 2005, Manganese porphyrin given at symptom onset markedly extends survival of ALS mice, Ann. Neurol., 58, 258, 10.1002/ana.20552 Cudkowicz, 2006, Trial of celecoxib in amyotrophic lateral sclerosis, Ann. Neurol., 60, 22, 10.1002/ana.20903 Cudkowicz, 2002, Survival in transgenic ALS mice does not vary with CNS glutathione peroxidase activity, Neurology, 59, 729, 10.1212/WNL.59.5.729 Drachman, 2002, Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS, Ann. Neurol., 52, 771, 10.1002/ana.10374 Dugan, 1997, Carboxyfullerenes as neuroprotective agents, Proc. Natl. Acad. Sci. U. S. A., 94, 9434, 10.1073/pnas.94.17.9434 Dupuis, 2004, Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model, Proc. Natl. Acad. Sci. U. S. A., 101, 11159, 10.1073/pnas.0402026101 Ermilova, 2005, Protection by dietary zinc in ALS mutant G93A SOD transgenic mice, Neurosci. Lett., 379, 42, 10.1016/j.neulet.2004.12.045 Feeney, 2003, The effect of leukaemia inhibitory factor on SOD1 G93A murine amyotrophic lateral sclerosis, Cytokine, 23, 108, 10.1016/S1043-4666(03)00217-5 Ferrante, 2001, Therapeutic efficacy of EGb761 (Gingko biloba extract) in a transgenic mouse model of amyotrophic lateral sclerosis, J. Mol. Neurosci., 17, 89, 10.1385/JMN:17:1:89 Friedlander, 1997, Inhibition of ICE slows ALS in mice, Nature, 388, 31, 10.1038/40299 Groeneveld, 2003, A randomized sequential trial of creatine in amyotrophic lateral sclerosis, Ann. Neurol., 53, 437, 10.1002/ana.10554 Gurney, 1997, The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies, J. Neurol. Sci., 152, S67, 10.1016/S0022-510X(97)00247-5 Gurney, 1994, Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation, Science, 264, 1772, 10.1126/science.8209258 Gurney, 1996, Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis [see comment], Ann. Neurol., 39, 147, 10.1002/ana.410390203 Hamadeh, 2005, Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse, Muscle Nerve, 31, 214, 10.1002/mus.20255 Holzbaur, 2006, Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis, Neurobiol. Dis., 10.1016/j.nbd.2006.05.009 Hottinger, 1997, The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis, Eur. J. Neurosci., 9, 1548, 10.1111/j.1460-9568.1997.tb01511.x Jiang, 2000, Beneficial effect of ginseng root in SOD-1 (G93A) transgenic mice, J. Neurol. Sci., 180, 52, 10.1016/S0022-510X(00)00421-4 Jung, 2001, Synthetic superoxide dismutase/catalase mimetics reduce oxidative stress and prolong survival in a mouse amyotrophic lateral sclerosis model, Neurosci. Lett., 304, 157, 10.1016/S0304-3940(01)01784-0 Karlsson, 2004, Life span extension and reduced neuronal death after weekly intraventricular cyclosporin injections in the G93A transgenic mouse model of amyotrophic lateral sclerosis, J. Neurosurg., 101, 128, 10.3171/jns.2004.101.1.0128 Kaspar, 2003, Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model, Science, 301, 839, 10.1126/science.1086137 Kaspar, 2005, Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis, Ann. Neurol., 57, 649, 10.1002/ana.20451 Keep, 2001, Intrathecal cyclosporin prolongs survival of late-stage ALS mice, Brain Res., 894, 327, 10.1016/S0006-8993(01)02012-1 Kiaei, 2006, Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis, J. Neurosci., 26, 2467, 10.1523/JNEUROSCI.5253-05.2006 Kieran, 2004, Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice [see comment], Nat. Med., 10, 402, 10.1038/nm1021 Kira, 2006, l-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis, Brain Res., 1070, 206, 10.1016/j.brainres.2005.11.052 Kirkinezos, 2004, An ALS mouse model with a permeable blood-brain barrier benefits from systemic cyclosporine A treatment, J. Neurochem., 88, 821, 10.1046/j.1471-4159.2003.02181.x Klivenyi, 2004, Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis, J. Neurochem., 88, 576, 10.1046/j.1471-4159.2003.02160.x Klivenyi, 1999, Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis, Nat. Med., 5, 347, 10.1038/6568 Koh, 2006, The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice, Neurosci. Lett., 395, 103, 10.1016/j.neulet.2005.10.056 Kostic, 1997, Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis, Science, 277, 559, 10.1126/science.277.5325.559 Kriz, 2002, Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis, Neurobiol. Dis., 10, 268, 10.1006/nbdi.2002.0487 Kriz, 2003, Efficient three-drug cocktail for disease induced by mutant superoxide dismutase, Ann. Neurol., 53, 429, 10.1002/ana.10500 Li, 2000, Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model, Science, 288, 335, 10.1126/science.288.5464.335 Manabe, 2002, Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis, Apoptosis, 7, 329, 10.1023/A:1016123413038 Maragakis, 2003, Topiramate protects against motor neuron degeneration in organotypic spinal cord cultures but not in G93A SOD1 transgenic mice, Neurosci. Lett., 338, 107, 10.1016/S0304-3940(02)01386-1 Mignini, 2006, Methodological quality of systematic reviews of animal studies: a survey of reviews of basic research, BMC Med. Res. Methodol., 6, 10, 10.1186/1471-2288-6-10 Miller, 2002, Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND), Cochrane Database Syst. Rev., 10.1002/14651858.CD001447 Miller, 2005, Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis, Ann. Neurol., 57, 773, 10.1002/ana.20453 Mohajeri, 1999, Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis, Hum. Gene Ther., 10, 1853, 10.1089/10430349950017536 Nagano, 2003, The efficacy of trientine or ascorbate alone compared to that of the combined treatment with these two agents in familial amyotrophic lateral sclerosis model mice, Exp. Neurol., 179, 176, 10.1016/S0014-4886(02)00014-6 Nagano, 1999, Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice, Neurosci. Lett., 265, 159, 10.1016/S0304-3940(99)00227-X Narai, 2005, Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice, J. Neurosci. Res., 82, 452, 10.1002/jnr.20668 Pamphlett, 2003, Magnesium supplementation does not delay disease onset or increase survival in a mouse model of familial ALS, J. Neurol. Sci., 216, 95, 10.1016/S0022-510X(03)00216-8 Petri, 2006, Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis, Neurobiol. Dis., 22, 40, 10.1016/j.nbd.2005.09.013 Poduslo, 2000, Therapeutic benefit of polyamine-modified catalase as a scavenger of hydrogen peroxide and nitric oxide in familial amyotrophic lateral sclerosis transgenics, Ann. Neurol., 48, 943, 10.1002/1531-8249(200012)48:6<943::AID-ANA18>3.0.CO;2-1 Pompl, 2003, A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis, FASEB J., 17, 725, 10.1096/fj.02-0876fje Ralph, 2005, Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model, Nat. Med., 11, 429, 10.1038/nm1205 Raman, 2004, Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid, Amyotroph. Lateral Scler. Other Mot. Neuron Disord., 5, 33, 10.1080/14660820310016813 Reinholz, 1999, Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis, Exp. Neurol., 159, 204, 10.1006/exnr.1999.7142 Rosen, 1993, Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, 362, 59, 10.1038/362059a0 Rothstein, 2005, Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression, Nature, 433, 73, 10.1038/nature03180 Ryu, 2005, Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice, J. Neurochem., 93, 1087, 10.1111/j.1471-4159.2005.03077.x Schutz, 2005, The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice, J. Neurosci., 25, 7805, 10.1523/JNEUROSCI.2038-05.2005 Shefner, 2004, A clinical trial of creatine in ALS, Neurology, 63, 1656, 10.1212/01.WNL.0000142992.81995.F0 Snow, 2003, Creatine supplementation and riluzole treatment provide similar beneficial effects in copper, zinc superoxide dismutase (G93A) transgenic mice, Neuroscience, 119, 661, 10.1016/S0306-4522(03)00212-4 Sugai, 2004, Benefit of valproic acid in suppressing disease progression of ALS model mice, Eur. J. Neurosci., 20, 3179, 10.1111/j.1460-9568.2004.03765.x Tortarolo, 2006, Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease, J. Neurosci. Res., 83, 134, 10.1002/jnr.20715 Trieu, 2000, A specific inhibitor of janus kinase-3 increases survival in a transgenic mouse model of amyotrophic lateral sclerosis, Biochem. Biophys. Res. Commun., 267, 22, 10.1006/bbrc.1999.1905 Turner, 2003, Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice, J. Neurosci. Res., 74, 605, 10.1002/jnr.10796 Turner, 2003, The serotonin precursor 5-hydroxytryptophan delays neuromuscular disease in murine familial amyotrophic lateral sclerosis, Amyotroph. Lateral Scler. Other Mot. Neuron Disord., 4, 171, 10.1080/14660820310009389 Turner, 2003, Antisense peptide nucleic acid-mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice, J. Neurochem., 87, 752, 10.1046/j.1471-4159.2003.02053.x Turner, 2004, Effect of p75 neurotrophin receptor antagonist on disease progression in transgenic amyotrophic lateral sclerosis mice, J. Neurosci. Res., 78, 193, 10.1002/jnr.20256 Van Den Bosch, 2002, Minocycline delays disease onset and mortality in a transgenic model of ALS, NeuroReport, 13, 1067, 10.1097/00001756-200206120-00018 Waibel, 2004, Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model, J. Neurol., 251, 1080, 10.1007/s00415-004-0481-5 Wang, 2002, Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis, J. Neurosci., 22, 6920, 10.1523/JNEUROSCI.22-16-06920.2002 West, 2004, The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A-SOD1 transgenic mice, J. Neurochem., 91, 133, 10.1111/j.1471-4159.2004.02700.x Wu, 2003, Iron porphyrin treatment extends survival in a transgenic animal model of amyotrophic lateral sclerosis, J. Neurochem., 85, 142, 10.1046/j.1471-4159.2003.01639.x Zhang, 2003, Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS, Ann. Neurol., 53, 267, 10.1002/ana.10476 Zhao, 2006, A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis, BMC Neurosci., 7, 29, 10.1186/1471-2202-7-29 Zheng, 2004, Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS, Ann. Neurol., 56, 564, 10.1002/ana.20223 Zhu, 2002, Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice, Nature, 417, 74, 10.1038/417074a